Leerink Partners Maintains Outperform on Intuitive Surgical, Lowers Price Target to $454

Benzinga Newsdesk www.benzinga.com Negative 94.7%

Neg 94.7% Neu 0% Pos 0%

Leerink Partners analyst Mike Kratky maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and lowers the price target from $573 to $454.